New York, October 29, 2015 -- Moody's Investors Service rated Envision Healthcare Corporation's ("Envision") proposed $750 million senior secured term loan due 2022 B1. At the same time, Moody's lowered the rating on the company's existing $1.28 billion senior secured term loan due 2018 to B1 from Ba3. Envision's B1 Corporate Family Rating (CFR), B1-PD Probability of Default Rating and B3 senior notes rating, and SGL-1 Speculative Grade Liquidity Rating were all affirmed. The outlook is stable.
Vollständigen Artikel bei Moodys lesen
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.